Facial Aesthetics (Botox, Dermal Fillers, Collagen)

Feb. 28, 2011 - PRLog -- The global market for facial aesthetics is forecast to reach about $4 billion in 2017 at a compound annual growth rate (CAGR) of 9%. The growth is expected to be driven by minimally invasive and non-invasive procedures that offer long term results at competitive pricing. The Botulinum toxin market is expected to maintain the lead in terms of market share, in spite of its high side effects profile. This is due to advantages such as better patient comfort, short procedure times and faster results. Hyaluronic acid based dermal fillers are primarily driven by their low side effects profile. The results of hyaluronic acid based fillers (HA fillers) are short term (three to six months) and as a result recurring income for physicians and aesthetic centers encourages growth of this segment. The particle and polymer fillers market will register lower growth rates compared to Botulinum toxin and HA fillers. Focus of companies on lower side effects profile and longevity of aesthetic results of up to two years encourage the future growth of this segment. Loss of recurring income due to long term results discourages physicians and aesthetic centers to suggest polymer fillers for their patients. Collagen products will experience continue to experience decline in the sales as it has been the historic trend.This is due to reasons such as increasing awareness about botulinum toxin and HA fillers and their reducing price trends.

For Sample Pages, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/RequestSamplePages....

The US contribution towards the global facial aesthetics market was valued at 39% in 2009. The US facial aesthetics market is forecast to reach $1.7 billion in 2017, with a CAGR of 11%. The market is expected to be driven by the popularity of botulinum toxin and hyaluronic acid based dermal fillers used for facial rejuvenation. Inception of DYSPORT from Medicis in mid-2009 is likely to affect Allergan’s domination for botulinum toxin products in the US. The competition has also resulted in decreasing price trends in the US and as a result will encourage new patients to go for botulinum toxin procedures. The market is also expected to be driven by an increasing number of providers, such as Merz Pharmaceuticals, diversifying into botulinum toxin based products and dermal fillers. The direct to consumer marketing approach of the companies is expected to increase awareness about facial aesthetics in the US. Non-invasive dermal fillers such as hyaluronic acid formulated with anesthetic lidocaine are being predominantly used in the US, which will drive the market for facial aesthetics in the US.

GlobalData’s new report, “Facial Aesthetics (Botox, Dermal Fillers, Collagen) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global facial aesthetics market. The report provides market landscape, competitive landscape and market trends information on the facial aesthetics market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts

For further details, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/Report.aspx?ID=Faci...

Visit our report store: http://www.globaldata.com

For more details contact:
pressreleases@globaldata.com            
North America:    +1 646 395 5477
Europe:        +44 207 753 4299
           +44 1204 543 533
Asia Pacific:       +91 40 6616 6782

# # #

GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage including oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries.